Education Course

Each fall, the course focuses on either pediatric oncologic neuro-imaging, covering all central nervous system (CNS) tumors, or pediatric oncologic body imaging, encompassing all non-CNS tumors, or pediatric image guided intervention as a rotating basis. This unique course serves as a platform for discussing the best practices in pediatric cancer imaging with the clinical community responsible for pediatric tumor care, particularly radiologists, both practicing and in training. Led by national and internal imaging experts, the course delves into the imaging characteristics of pediatric cancers, state-of-the-art techniques, response assessment systems, tumor biology, and management. It offers a specialized opportunity to enhance knowledge and expertise in this critical field. The course is delivered to a limited number of attendees to make sure that there are formal and informal interactions the faculty. The course offers AMA category 1 CME credits.

The Society for Pediatric Radiology and the St. Jude Pediatric Biomedical Imaging Initiative are jointly hosting a Pediatric Oncologic Imaging Course February 5-6, 2026 St. Jude Children's Research Hospital Memphis, TN

This two-day hybrid course—offered both in person and online—provides a dynamic and comprehensive exploration of pediatric oncologic imaging. Designed to elevate diagnostic accuracy, care quality, and clinical innovation, the  program highlights state-of-the-art practices across the field. Sessions will delve into the patient impact of imaging decisions, advances in precision medicine, breakthroughs in nuclear medicine, emerging applications of artificial  intelligence, and core principles of neuro-oncologic imaging and standardized response assessment. Participants will engage with challenging real-world cases and gain practical insight into long-term surveillance strategies, treatment- related complications, and sustainable imaging approaches. Together, these components equip learners with forward-looking tools to enhance practice and improve outcomes for children with cancer.